ENFR

Omega Pharma and Madestea

September 2004

Omega Pharma, the Belgium group listed on Euronext, has acquired Madestea, the leading cosmetics and food supplements player on the Italian OTC market under the Sant’Angelica brand.

Ohana & Co. acted as the exclusive financial advisor to Omega Pharma.


Press release

Related Transactions

December 2017 Cegedim, an innovative technology and services company listed in Paris (EURONEXT : CGM), has signed an acquisition agreement with Societe Generale covering its Cegelease business, a subsidiary operating in the financial leasing sector. Founded in 2001 to support Cegedim's sales to its customers with leasing solutions, the company has gradually expanded its activities by financing the sales of other suppliers. With nearly 500 suppliers and more than 25,000 clients Cegelease has established itself as one of the independent leaders in financial leasing for healthcare professionals. With 31 million customers in 66 countries, and over € 25 billion in net banking income, Société Générale is one of the largest European financial services groups. Societe Generale , through its subsidiary Franfinance, is one of the leaders in the equipment financing for companies and sees the healthcare market as a key area for growth. This acquisition, which is subject to the approval of competition authorities, will enable Franfinance to strengthen its position in this market and create a major player in the field of financing for healthcare professionals. Ohana & Co. acted as exclusive financial advisor to the seller, the Cegedim group.

Read more

Sun City Group (France), one of the largest European players in licensed “characters” for kids wear (Mickey Mouse, Cars, Toy Story, Hello Kitty, etc.), has led an ownership buyout (OBO) backed by Edmond de Rothschild Investment Partners. Ohana & Co. acted as the exclusive financial advisor to Sun City Group and its shareholders.

Read more

Waterland Private Equity Investments (Netherlands) has acquired Omega Pharma’s interest in Arseus NV (Belgium). Arseus’s main entity, Fagron, is the European leader in pharmaceutical compounding and has operations in Europe, the US and Brazil. Ohana & Co. acted as the exclusive financial advisor to Arseus.

Read more